NASDAQ: OMGAOmega Therapeutics Inc Stock Ownership - Who owns Omega Therapeutics?
Insider buying vs selling
Have Omega Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard A. Young | Director | 2023-06-02 | 5,000 | $8.00 | $40.00kSell |
| Richard A. Young | Director | 2023-05-01 | 5,000 | $8.00 | $40.00kSell |
| Richard A. Young | Director | 2023-04-06 | 5,000 | $8.00 | $40.00kSell |
| Richard A. Young | Director | 2023-03-17 | 10,000 | $8.00 | $80.00kSell |
| Flagship Pioneering Inc | 10% Owner | 2023-02-27 | 1,329,324 | $5.78 | $7.68MBuy |
| Flagship Pioneering Inc | 10% Owner | 2023-02-27 | 1,993,986 | $5.78 | $11.53MBuy |
| Richard A. Young | Director | 2023-01-10 | 20,000 | $8.00 | $160.00kSell |
OMGA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OMGA insiders and whales buy or sell their stock.
OMGA Shareholders
What type of owners hold Omega Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Flagship Pioneering Inc | 56.99% | 31,422,638 | $58.76M | Insider |
| Flagship Pioneering Inc | 53.00% | 29,225,579 | $54.65M | Institution |
| Fmr LLC | 9.42% | 5,194,102 | $9.71M | Institution |
| Harbourvest Partners LLC | 6.37% | 3,512,110 | $6.57M | Institution |
| Artal Group Sa | 4.59% | 2,533,045 | $4.74M | Institution |
| Invus Public Equities LP | 4.12% | 2,273,530 | $4.25M | Insider |
| State Of Wisconsin Investment Board | 3.37% | 1,857,265 | $3.47M | Institution |
| Blackrock Inc | 2.77% | 1,529,939 | $2.86M | Institution |
| Vanguard Group Inc | 2.69% | 1,485,635 | $2.78M | Institution |
| Flagship Pioneering Fund Vii General Partner LLC | 2.41% | 1,329,324 | $2.49M | Insider |
OMGA vs Biotech Stocks
Omega Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.